Implementing Solutions To Virtualize And Decentralize Clinical Trials

Traditional clinical trials are multi-site human studies that integrate numerous in-person study visits and endpoints. However, as clinical studies become more complex, it is more important than ever to develop new trial models that can accommodate novel endpoints and provide greater flexibility to study participants.

The increasing complexity and number of on-site visits and procedures also has a direct effect on patient recruitment, retention, study timelines and costs. This white paper describes how one solution to address some of these limitations of traditional clinical trials has been the emergence of decentralized clinical trials (DCTs).